Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page remains on a 403 Forbidden error screen, with no visible change to its content or layout.
    Difference
    0.2%
    Check dated 2026-10-03T16:13:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, replacing the study details with a standard error page. As a result, access to the study record and related information is blocked.
    Difference
    17%
    Check dated 2026-09-19T19:14:13.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    An NIH grant/contract note for 2017 was added, and the page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:31:49.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.4 to v3.6.5, signaling a minor version update to the page. It does not change the substantive study details or visible information.
    Difference
    0.1%
    Check dated 2026-08-08T18:23:31.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a software version update for the site. This update does not change the displayed trial information or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-07-25T08:46:52.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 on the page, indicating a software deployment update.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:24.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.